Enjamb Labs logo

Enjamb Labs

Where drug teams run their entire program, discovery to FDA approval

Spring 2026B2B / B2BSan Francisco, CA, USA2 employees
Artificial Intelligence
SaaS
B2B
Biotech
Automation

About

Enjamb runs the entire drug program for biopharma teams, from discovery to FDA approval. Pharma runs on decades of closed legacy systems like Benchling, Veeva, Medidata, and SAS, with no AI layer and no MCP to connect agents to them. So we built that connection layer in one platform. Our agents run on top of their existing systems and data, with no migration, and do the work across the whole program: clinical evidence, trial design, statistical programming, and regulatory submissions. In just 3 weeks since launch, we're already being used by 500+ employees at top pharma companies, including Johnson & Johnson, AbbVie, Bristol Myers Squibb, Merck & Sanofi.

Build your own investing agent

GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.

Join the GPAgent waitlist

Founders (2)

Maadhav Deekshitha
Founder
Rayan Mubarak
Founder

Details

Status
Active
Stage
Early
Team Size
2
Regions
United States of America, America / Canada